Hem › Medulloblastom › Kalifornien
Kliniska studier för Medulloblastom i Kalifornien
6 studier för Medulloblastom söker deltagare vid platser i Kalifornien.
Städer i Kalifornien
Officiell studietext (engelska)
Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease
- University of California, San Francisco, San Francisco
RekryterarFas 1/2
Ålder 1 till 25 · Alla kön · Uppdaterad 28 sep. 2026 · NCT07346157Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- Lucille Packard Children's Hospital Stanford, Palo Alto
RekryterarFas 2
59 Months · Alla kön · Uppdaterad 15 sep. 2026 · NCT05535166GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
- Lucile Packard Children's Hospital Stanford, Palo Alto
RekryterarFas 1
Ålder 1 till 30 · Alla kön · Uppdaterad 11 sep. 2026 · NCT07087002A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Loma Linda University Medical Center, Loma Linda
- Miller Children's and Women's Hospital Long Beach, Long Beach
- Children's Hospital Los Angeles, Los Angeles
- och 6 fler
RekryterarFas 3
Ålder 4 till 21 · Alla kön · Uppdaterad 25 aug. 2026 · NCT05382338DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- UCSF Benioff Children's Hospital Oakland, Oakland
- UC Davis Comprehensive Cancer Center, Sacramento
- Rady Children's Hospital, San Diego
- och 1 fler
RekryterarFas 2
Upp till ålder 21 · Alla kön · Uppdaterad 12 aug. 2026 · NCT04696029Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
- Children's Hospital of Los Angeles, Los Angeles
- Rady Children's Hospital, San Diego
- University of California, San Francisco, San Francisco
Rekryterar
12 Months – 39 Years · Alla kön · Uppdaterad 11 aug. 2026 · NCT05057702Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.